NCT04394195View on ClinicalTrials.gov

sFlt1: a Biomarker of Organ Dysfunction in Critically-ill Patients With COVID-19?

CompletedOBSERVATIONAL
Enrollment

72

Participants

Timeline

Start Date

April 3, 2020

Primary Completion Date

May 1, 2020

Study Completion Date

September 1, 2020

Conditions
CORONAVIRUS INFECTIONS
Interventions
OTHER

measurement of circulating sFlt1 concentration

blood circulating sFlt1 concentration will be determined

Trial Locations (1)

51092

Chu Reims, Reims

All Listed Sponsors
lead

CHU de Reims

OTHER

NCT04394195 - sFlt1: a Biomarker of Organ Dysfunction in Critically-ill Patients With COVID-19? | Biotech Hunter | Biotech Hunter